Amana Healthcare - Bahrain, built on the proven and trusted M42 model of Amana Healthcare in the UAE, highlights the successful exchange of specialized healthcare expertise between the UAE and Bahrain.

Manama, Kingdom of Bahrain : Amana Healthcare Bahrain was honored to welcome His Excellency Mr. Fahad Mohammed Salem Kardous Al Ameri, Ambassador of the United Arab Emirates to the Kingdom of Bahrain, at its facility in Al Jasra. He was received by Dr. Mohammed Amin Al Saati, CEO of M42 Bahrain, along with a number of senior staff members from both M42 Bahrain and Amana Healthcare Bahrain.

The talks highlighted the deep-rooted historical ties between Bahrain and the United Arab Emirates, which continue to flourish under the leadership and support of His Majesty King Hamad bin Isa Al Khalifa, King of Bahrain, and His Highness Sheikh Mohammed bin Zayed Al Nahyan, President of the United Arab Emirates. The meeting also underscored the importance of ongoing cooperation between the two sisterly nations within the Gulf Cooperation Council across vital sectors, most notably healthcare, innovation, and human development.

Dr. Mohammed Amin Al Saati pointed out that the presence of M42 , a global leader in healthcare based in Abu Dhabi, and its continued expansion in the Kingdom of Bahrain, strongly indicates the spirit of cooperation between Bahrain and the United Arab Emirates, stressing the pivotal role of this partnership in driving innovation, exchanging experiences, and creating important job opportunities that contribute to improving healthcare outcomes and the quality of life for communities across the region.

During the visit, His Excellency the Ambassador toured the state-of-the-art Amana Healthcare Bahrain facility, where he was briefed on the hospital's specialized services, advanced rehabilitation capabilities, and human-centered care model. The tour included rehabilitation and treatment facilities such as a hydrotherapy pool, specialized training rooms, and a care environment designed to support recovery, healing, and promote long-term health.

Amana Healthcare – Bahrain is a prime example of the exchange of specialized healthcare knowledge and expertise between the UAE and the Kingdom of Bahrain. Established in strategic partnership with Bahrain Mumtalakat Holding Company (Mumtalakat), M42 has for the first time expanded its pioneering and proven model of long-term post-acute rehabilitation beyond the UAE, making Amana Healthcare – Bahrain the first facility of its kind in the Kingdom.

Since its opening, Amanah Healthcare – Bahrain has become a key partner in Bahrain’s healthcare system, providing world-class, people-centered care in a compassionate, home-like environment. The Al Jasra facility spans over 15,000 square meters, has more than 100 beds, and is supported by a multidisciplinary team of over 150 healthcare professionals dedicated to improving patient outcomes and enhancing their quality of life.

The visit reaffirmed the shared commitment of the Kingdom of Bahrain and the United Arab Emirates to promote excellence in healthcare, strengthen regional cooperation, and drive sustainable economic growth through strategic partnerships that place people, society, and quality of life at the heart of development paths.

About Amanah Healthcare – Bahrain

Amana Healthcare – Bahrain, part of the M42 Group in partnership with Mumtalakat, is the first facility of its kind in the Kingdom of Bahrain designed entirely to provide specialized, long-term post-acute rehabilitation care. Leveraging Amana Healthcare’s proven and trusted experience in the UAE since 2013, Amana Healthcare – Bahrain offers personalized treatment plans, compassionate care, and a home-like, friendly environment, designed to support patients and their families every step of the way through their treatment and recovery journey.

For media inquiries:

Manal Salibikh

Marketing Manager

Amanah Healthcare - Bahrain

msulaibeekh@amanahealthcare.bh

-I finish-

#Company Data

Disclaimer regarding the content of press releases
The content of this press release is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an "as is" and "as available" basis and is not edited in any way. Neither we, nor our affiliates, will be liable for the accuracy, endorsement, or completeness of any opinions, views, information, or materials contained in this content.
This press release is provided for informational purposes only; the content does not constitute legal, investment, or tax advice, nor does it offer any opinion on the suitability, value, or profitability of any particular portfolio or investment strategy. Neither we nor our affiliates will be liable for any errors or inaccuracies in the content, or for any actions you take based on that content. You expressly agree and acknowledge full responsibility for your use of the information contained in this press release.
To the extent permitted by applicable law, Refinitiv, its parent company, subsidiaries, affiliates, relevant shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the 'Refinitiv Parties') shall not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to, losses of profits, savings, or revenues, whether due to negligence, tort, contract, or other theories of liability, even if the parties to Refinitiv were advised of the possibility of any such damages or losses occurring or actually anticipated them.